Teva Octreotide For Injectable Suspension Recalled Due To Potential Drug Quality Issues
Teva is recalling all strengths of Teva Octreotide for Injectable Suspension Kit across Canada due to potential product quality issues. The recall affects specific lot numbers of this injectable medication used to treat certain medical conditions. The affected products were distributed throughout Canada.
- Product
- All strengths of Teva Octreotide for Injectable Suspension Kit (DIN 02503751, 02503778 and 0253786) with the lot numbers noted below.
- Reason
- Product quality concern
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2026-01-13
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/849c35b4-2771-40ff-a001-70fd1f3e5580